Cyclodextrin News

Next-generation contact lenses: Towards bioresponsive drug delivery and smart technologies in ocular therapeutics,

In this comprehensive review the numerous disadvantages of contact lenses as medicated lenses and the strategies to overcome the same

BioJapan is Asia’s premier hyrid partnering event held on October 13–15, 2021 in Yokohama, Japan. This event is consituted by

The most common method to modify cellular cholesterol content in vitro is to incubate cells with cyclodextrin (CD). However, it

Using MD simulations, the possible role of SBE-β-CDs aggregates in the solubilization of remdesivir was studied. Both the effect of

Inflammation is one of the usual biological responses to different pathologies or stimuli. As the incidence of inflammation related diseases

Cyclodextrin (CD) are classicaly know to be an excellent drug carrier although applications as active drug have been studied (orphan

Memorial Sloan Kettering Cancer Center (MSKCC) has filed a patent application on an inhalational therapeutic composition of camostat solubilized by

Zhao et al. reported on a phase IIa, single-center, randomized, open-label, and dose-finding study that enrolled 35 patients under general

Underdog Pharmaceuticals, a key investment of Michael Greve’s rejuvenation biotech VC Kizoo, has closed a $10 million round of capital.

After the great success of the webinar held in May, 2021 a next webinar organized by CycloLab will be held